EIF4A2 and prostate carcinoma: High EIF4A2 level was prognostic of poor prognosis in liver cancer, head and neck cancer, melanoma and prostate cancer by TCGA data analysis, which was in accordance with our results that EIF4A2 was associated with poor prognosis in CRC.